Experienced Researcher Will Focus on Importance of Animals in Biomedical Research
Louis DeTolla, Jr., VMD, MS, PhD, Professor of Pathology, Medicine, and Epidemiology & Public Health at the University of Maryland School of Medicine (UM SOM) as well as founding director in the Department of Comparative Medicine and Chief of Veterinary Resources, has been appointed to the Board of Directors for the National Association for Biomedical Research (NABR).
On behalf of its more than 350 universities, medical schools, teaching hospitals, and pharmaceutical industries, the NABR provides a unified voice for the scientific community on legislative and regulatory matters affecting laboratory animal research. Dr. DeTolla’s appointment provides UM SOM with an avenue to improve regulatory guidelines that benefit animal research productivity.
Dr. DeTolla regularly collaborates with a wide range of investigators who use animal models, especially in the area of infectious diseases, transgenics, biohazards, biodefense, primatology and vaccine development. His work is funded by the National Institutes of Health, the Department of Defense, and industry entities.
Dr. DeTolla received a BA from Temple University in 1970, an MS in microbiology from Rutgers University in 1974, and a PhD in pathology and immunology, also from Rutgers, in 1978. In 1982, he received his VMD from the University of Pennsylvania School of Veterinary Medicine.
Dr. DeTolla began his career as a research veterinarian and immunochemist at Sloan-Kettering Institute for Cancer Research. He went from there to the Fox Chase Cancer Center, where he was a research and attending veterinarian, and a cancer biologist and chair of the Animal Care Committee in the Division of Clinical Research, and then to the Merck Institute for Therapeutic Research, where he was a research veterinarian and co-director of laboratory animal resources at the Sharp & Dohme Research Laboratories. In 1988, he joined UM SOM in the positions he still holds today.
Dr. DeTolla is a longtime member of numerous professional associations, including the American College of Laboratory Animal Medicine, the American Society of Laboratory Animal Practitioners, the American Association for the Advancement of Science, and the American College of Laboratory Animal Medicine. He has also received many honors and awards.
“Dr. DeTolla has devoted much of his career to animal research,” said UM SOM Dean E. Albert Reece, MD, PhD, MBA, who is also Vice President of Medical Affairs at the University of Maryland and the John Z. and Akiko Bowers Distinguished Professor at UM SOM. “This new position will allow him to continue to play a significant role in this crucial area of science.”
About the University of Maryland School of Medicine
The University of Maryland School of Medicine was chartered in 1807. It was the first public medical school in the U.S. and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland’s Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world.
About the National Association for Biomedical Research
The National Association for Biomedical Research is dedicated solely to advocating for sound public policy that recognizes the vital role animals play in biomedical research. On behalf of the biomedical research community, the association champions sound public policy in support of ethical and essential laboratory animal research. With an increase in animal activist campaigns against researchers, the National Association for Biomedical Research works to furnish legislators with the facts and to educate them on the impact proposed changes would have on medical progress. It plays a central role in assuring that new federal laws and regulations meet animal welfare and biomedical research needs.